TrialDiabetologia2023

Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.

Søren Gullaksen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.